Axsome Therapeutics Operating Expenses 2014-2024 | AXSM
Axsome Therapeutics operating expenses for the twelve months ending December 31, 2024 were $0.666B, a 32.61% increase year-over-year.
- Axsome Therapeutics annual operating expenses for 2024 were $0.666B, a 32.61% increase from 2023.
- Axsome Therapeutics annual operating expenses for 2023 were $0.502B, a 118.6% increase from 2022.
- Axsome Therapeutics annual operating expenses for 2022 were $0.23B, a 84.3% increase from 2021.
Historical Chart (TTM)
Quarterly
Quarterly - YOY Change
Annual
Annual % Change